| Bone 
			regeneration study          
 Send a link to a friend 
            
            [DEC. 26, 2006]  
            
            
            URBANA 
			-- Five years from now, human testing might be under way on the 
			fruits of a large-scale research project that includes the
			University of Illinois 
			Department of Animal Sciences. In essence, the project seeks to 
			grow new bone and other tissue in humans by using techniques 
			perfected in swine. | 
        
            | "Pigs are a good biological model for humans," explains Matt 
			Wheeler, a professor in the department who is also affiliated with 
			the U of I's Institute for 
			Genomic Biology. "Because of the biological similarities, pigs 
			provide good opportunities to work out technologies before you go to 
			human trials." Wheeler's portion of the project -- which also 
			involves Russ Jamison and Amy Wagner-Johnson of the College of 
			Engineering and Dr. Michael Goldwasser, a maxillofacial surgeon with 
			the U of I College of Medicine -- deals with developing technologies 
			to generate therapies to replace bone lost in humans due to cancer 
			of the jaw, severe periodontal disease and traumatic injury. Larry Schook, also of the U of I Department of Animal Sciences 
			and leader of the regenerative biology and tissue engineering theme 
			for the Institute for Genomic Biology, is also part of the larger 
			project funded by the
			Illinois 
			Regenerative Medicine Institute, a state agency. 
             "I'm working on developing methods to isolate and purify cells 
			that can be used in the studies by building technologies to isolate 
			cells from adult stem cells and purify them for use," he says. Eventually, Schook says, the findings in pigs could be applied to 
			humans to address a range of diseases and injuries that destroy 
			tissue. "For instance, heart attacks and strokes destroy muscles and 
			tissues," he says. "What if you could use adult stem cells to 
			regenerate those damaged tissues? There could be many opportunities 
			to help the healing process." One example is the growing need for knee replacements in young 
			women who are injured playing sports at a young age. When they 
			finally need knee replacement surgery, the artificial equipment 
			involved will last only about 10 to 15 years. 
            [to top of second column] 
            
             | 
            
             
            
            "That means a young woman could face a number of knee replacement 
			surgeries throughout her lifetime," Schook says. "But if you could 
			get the body to regenerate that damaged tissue, you eliminate the 
			need for surgery." Wheeler's work involves the specific problems associated with 
			replacing jawbones. "Now, if someone loses a portion of the jawbone due to disease or 
			injury, you have to go somewhere else in their body -- the ribs, for 
			example -- to find bone to replace it," he says. "That can be 
			terribly painful, plus involve extensive surgeries." Wheeler and his colleagues are taking an interdisciplinary 
			approach to develop "scaffolds" upon which the body can rebuild bone 
			through the use of cells that are "pushed" toward regeneration. The "scaffolds" essentially involve materials that are compatible 
			with the body and around which the cells can rebuild tissue. The 
			engineers are focusing on this work. "I've developed some robotic methodologies that push cells toward 
			making bone," says Wheeler. "We're using adult pig stem cells from 
			fat and bone marrow, and we've had some success in vitro and with 
			the scaffolds in some animals." This work is also partially funded by the Illinois Regenerative 
			Medicine Institute. 
            
             In the future, patients needing some form of bone replacement 
			could simply have 5 grams of fat removed from their body, harvested 
			for stem cells and then have the cells used to rebuild the necessary 
			bone tissue. "We're hoping that within the next couple of years we'll have a 
			good handle on the swine model for this process," says Wheeler. 
			"Then on to clinical trials, and perhaps we'll see studies in humans 
			within five years." 
            [University 
			of Illinois Extension news release] |